Published in Am J Obstet Gynecol on October 30, 2008
Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice. J Urol (2013) 1.58
The impact of obesity on urinary incontinence symptoms, severity, urodynamic characteristics and quality of life. J Urol (2009) 1.55
Clinical and pathophysiological correlates of the symptom severity of stress urinary incontinence. Int Urogynecol J (2010) 0.88
Association of baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery. Neurourol Urodyn (2012) 0.78
Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med (1994) 18.43
The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol (1992) 13.63
Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res (1994) 6.73
Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn (1995) 6.30
Stress urinary incontinence: relative importance of urethral support and urethral closure pressure. J Urol (2008) 2.52
Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J Urol (1991) 2.49
Vaginal wall descensus and pelvic floor symptoms in older women. Obstet Gynecol (2005) 2.45
Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol (1986) 2.43
Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol (1993) 2.06
Negative Q-tip test as a risk factor for failed incontinence surgery in women. J Reprod Med (1989) 1.53
Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire. Urology (1999) 1.39
American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life. Urology (2003) 1.30
The significance of the American Urological Association symptom index score in the evaluation of women with bladder outlet obstruction. J Urol (2000) 1.09
The cost-effectiveness of preoperative testing (basic office assessment vs. urodynamics) for stress urinary incontinence in women. BJU Int (2002) 1.05
The correlation of multichannel urodynamic pressure-flow studies and American Urological Association symptom index in the evaluation of benign prostatic hyperplasia. J Urol (1995) 1.01
Evaluation of Aa point and cotton-tipped swab test as predictors of urodynamic stress incontinence. Obstet Gynecol (2005) 1.00
The effect of pelvic organ prolapse on lower urinary tract function. Yonsei Med J (2003) 0.96
American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia. J Urol (1993) 0.94
Is urethral mobility really being assessed by the pelvic organ prolapse quantification (POP-Q) system? Obstet Gynecol (2002) 0.93
Symptom severity and QOL scales for urinary incontinence. Gastroenterology (2004) 0.92
Does pelvic organ prolapse quantification exam predict urethral mobility in stages 0 and I prolapse? Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.91
Correlation of the AUA symptom index with urodynamics in patients with suspected benign prostatic hyperplasia. Neurourol Urodyn (1994) 0.90
Urinary incontinence symptom scores and urodynamic diagnoses. Neurourol Urodyn (2002) 0.90
Lack of correlation of the American Urological Association Symptom 7 Index with urodynamic bladder outlet obstruction. Neurourol Urodyn (1996) 0.88
Correlation of Q-tip values and point Aa in stress-incontinent women. Obstet Gynecol (2007) 0.86
Association between valsalva and cough leak point pressures and pelvic organ prolapse quantification in women with stress incontinence. J Urol (2005) 0.83
Effect of anatomic urethral length on the correlation between the Q-tip test and descent at point Aa of the POP-Q system. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.82
Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med (2012) 24.06
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature (2009) 12.58
Integrative molecular concept modeling of prostate cancer progression. Nat Genet (2006) 8.49
Autoantibody signatures in prostate cancer. N Engl J Med (2005) 7.56
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol (2011) 6.54
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell (2005) 6.04
Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet (2006) 5.65
Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst (2006) 5.42
Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol (2011) 5.01
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res (2006) 4.99
Comparison of levator ani muscle defects and function in women with and without pelvic organ prolapse. Obstet Gynecol (2007) 4.34
Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med (2006) 4.09
Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol (2007) 3.37
A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res (2008) 3.35
National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology (2006) 3.34
Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia. Urology (2013) 3.31
Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA (2013) 3.08
The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell (2008) 2.87
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol (2005) 2.84
The increasing incidence of newborn circumcision: data from the nationwide inpatient sample. J Urol (2005) 2.76
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clin Cancer Res (2013) 2.70
Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Sci Transl Med (2011) 2.62
Stress urinary incontinence: relative importance of urethral support and urethral closure pressure. J Urol (2008) 2.52
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin Cancer Res (2009) 2.51
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Neoplasia (2006) 2.39
Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol (2004) 2.39
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiol Biomarkers Prev (2010) 2.36
Nocturia and quality of life: results from the Boston area community health survey. Eur Urol (2011) 2.34
Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys (2006) 2.33
NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw (2010) 2.31
Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population. Urology (2011) 2.26
Predictors of physician career satisfaction, work-life balance, and burnout. Obstet Gynecol (2007) 2.25
Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study. Urology (2013) 2.08
Prostate cancer early detection. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2007) 2.06
Beyond PSA: the next generation of prostate cancer biomarkers. Sci Transl Med (2012) 2.00
Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer (2005) 1.93
Long-term outcomes after primary failures of artificial urinary sphincter implantation. Urology (2012) 1.85
Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol (2003) 1.83
Complications requiring reoperation following vaginal mesh kit procedures for prolapse. Am J Obstet Gynecol (2008) 1.77
On the biomechanics of vaginal birth and common sequelae. Annu Rev Biomed Eng (2009) 1.77
Patient education materials about the treatment of early-stage prostate cancer: a critical review. Ann Intern Med (2004) 1.71
Outcome of urethral closure in patients with neurologic impairment and complete urethral destruction. Neurourol Urodyn (2006) 1.70
Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection. J Urol (2009) 1.68
Surgeon characteristics and long-term trends in the adoption of laparoscopic radical nephrectomy. J Urol (2011) 1.64
Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med (2012) 1.64
Long-term durability and functional outcomes among patients with artificial urinary sphincters: a 10-year retrospective review from the University of Michigan. J Urol (2008) 1.64
Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol (2005) 1.63
Impact of surgical volume on mortality and length of stay after nephrectomy. Urology (2004) 1.62
Long-term patient reported outcome and satisfaction after oral mucosa graft urethroplasty for hypospadias. J Urol (2005) 1.62
Utility of extended pattern prostate biopsies for tumor localization: pathologic correlations after radical prostatectomy. Cancer (2008) 1.60
Trends in medical management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology (2013) 1.58
Use of multiple imputation to correct for nonresponse bias in a survey of urologic symptoms among African-American men. Am J Epidemiol (2002) 1.58
Intraoperative nerve stimulation with measurement of urethral sphincter pressure changes during radical retropubic prostatectomy: a feasibility study. J Urol (2003) 1.55
Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy. J Urol (2012) 1.52
The efficacy and safety of combined therapy with α-blockers and anticholinergics for men with benign prostatic hyperplasia: a meta-analysis. J Urol (2013) 1.52
Use of nephrectomy at select medical centers--a case of follow the crowd? J Urol (2006) 1.47
The regionalization of radical cystectomy to specific medical centers. J Urol (2005) 1.47
The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol (2003) 1.46
Age effects on internal anal sphincter thickness and diameter in nulliparous females. Dis Colon Rectum (2007) 1.46
Certificate of need regulations and the diffusion of intensity-modulated radiotherapy. Urology (2012) 1.45
Reliability of health-related quality-of-life measures 1 year after surgical procedures for pelvic floor disorders. Am J Obstet Gynecol (2005) 1.44
Postoperative complications and long-term survival among patients treated surgically for renal cell carcinoma. J Urol (2011) 1.44
Evidence-based patient choice: a prostate cancer decision aid in plain language. BMC Med Inform Decis Mak (2005) 1.44
Efficacy and preoperative prognostic factors of autologous fascia rectus sling for treatment of female stress urinary incontinence. Urology (2011) 1.42
Certificate of need legislation and the dissemination of robotic surgery for prostate cancer. J Urol (2012) 1.42
Self-report of difficult defecation is associated with overactive bladder symptoms. Neurourol Urodyn (2010) 1.39
Cancer survivorship: challenges and changing paradigms. J Urol (2008) 1.36
Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer. Urol Oncol (2011) 1.36
Does vaginal closure force differ in the supine and standing positions? Am J Obstet Gynecol (2005) 1.35
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev (2005) 1.33
The effects of adjusting for case mix on mortality and length of stay following radical cystectomy. J Urol (2006) 1.31
Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry. Urology (2009) 1.31
Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI). Cancer (2007) 1.30
Variations in quality of care for men with early-stage prostate cancer. J Clin Oncol (2008) 1.29
Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology (2004) 1.29
Volume-based referral for cancer surgery: informing the debate. J Clin Oncol (2007) 1.29
Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol (2009) 1.29
Laparoscopy for renal cell carcinoma: diffusion versus regionalization? J Urol (2006) 1.28
Levator plate angle in women with pelvic organ prolapse compared to women with normal support using dynamic MR imaging. Am J Obstet Gynecol (2006) 1.27
Contemporary epidemiology of bladder exstrophy in the United States. J Urol (2005) 1.27
Heterogeneity in anatomic outcome of sacrospinous ligament fixation for prolapse: a systematic review. Obstet Gynecol (2007) 1.27
Non-surgical management of stress urinary incontinence: ambulatory treatments for leakage associated with stress (ATLAS) trial. Clin Trials (2007) 1.26
Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. J Urol (2006) 1.25
Outcomes of transvaginal uterosacral ligament suspension: systematic review and metaanalysis. Am J Obstet Gynecol (2010) 1.23
Regionalization of percutaneous nephrolithotomy: evidence for the increasing burden of care on tertiary centers. J Urol (2006) 1.23